Kellanova reported its first quarter 2025 results, with GAAP net sales decreasing by 4% year-on-year to $3.083 billion, primarily due to negative foreign currency translation. However, organic net sales increased by 1%, driven by emerging markets. Reported operating profit increased by 9% to $430 million, benefiting from the lapping of prior-year restructuring charges, while adjusted operating profit decreased by 13% to $441 million. Reported diluted earnings per share increased by 12% to $0.87, but adjusted diluted earnings per share decreased by 11% to $0.90.
Net sales were impacted by negative currency translation and widespread category softness, but the Company sustained growth on an organic basis, led by its emerging markets.
Operating profit growth benefited from lapping prior-year restructuring charges, while declining as expected on an adjusted-basis.
Earnings per share growth was driven by the lapping of prior-year restructuring charges and a lower effective tax rate.
Due to the pending merger with Mars, Incorporated, Kellanova will not be providing forward-looking guidance.
Due to the pending merger with Mars, Incorporated, Kellanova will not be providing forward-looking guidance.
Visualization of income flow from segment revenue to net income